Seven of the Heart Research Institute’s scientists have been recognised as world leaders in their research fields by being awarded prestigious NSW Cardiovascular Research Capacity Building Grants for their work.
“This is an exceptional result. It means a much-needed injection of funding to the Heart Research Institute, leading to a better outcome for patients with heart disease, stroke, high blood pressure, preeclampsia and diabetes,” says Professor Shaun Jackson, Director of Cardiovascular Research at HRI.
Senior Research Grants
- Professor Shaun Jackson, Heart Research Institute and The University of Sydney: Investigation of a new prothrombotic mechanism linking to cardiovascular disease
- Associate Professor Simone Schoenwaelder, Heart Research Institute and The University of Sydney: Towards the development of safer anticoagulants for the treatment of
- Professor Angela Makris, Heart Research Institute and Western Sydney University: as a major independent risk factor for cardiovascular disease. What is it about preeclampsia that makes for cardiovascular risk, and is it preventable?
- Professor David Celermajer, Heart Research Institute and The University of Sydney: Improving Health Outcomes in for Young Adults, their Families and the Health System
Early Mid-Career Research Grants
- Dr Freda Passam, Heart Research Institute and The University of Sydney: Targets for the prevention of cardiovascular in metabolic syndrome
- Dr Paul Coleman, Heart Research Institute, Centenary Institute and The University of Sydney: Redox control of processing and activity during thrombotic diseases
- Associate Professor Sanjay Patel, Heart Research Institute and The University of Sydney: The COLCARDIO-ACS Study – Cardiovascular Outcomes in Acute Coronary Syndrome Study - Imaging/Biomarker Substudy
“We can continue to work towards our goal, which is to reduce the burden of cardiovascular disease,” Professor Jackson states.
The Cardiovascular Disease Research Capacity Building Program
The Cardiovascular Disease Research Capacity Building Program was conceived in June 2018, when the a $150 million investment over 10 years into cardiovascular research. The grants support high-quality cardiovascular researchers to drive scientific discoveries, support the development of novel and innovative therapies, and improve health outcomes for patients with cardiovascular disease. In addition, the grants will increase the national and international competitiveness of NSW cardiovascular research.
This initiative was driven by the state’s leading cardiovascular research institutes, including the Heart Research Institute and the Victor Chang Cardiac Research Institute. The collaboration was the first time in history that the NSW cardiovascular medical research community lobbied to government with one voice and one vision.
